search
Back to results

The With Or Without Olecranon K-wires Trial (WOW-OK)

Primary Purpose

Olecranon Fracture

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Cerclage fixation
Tension band wiring
Sponsored by
Region Skane
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Olecranon Fracture focused on measuring Tension Band Wiring, Cerclage, Surgery, Elbow injuries, Forearm injuries, Ulna fractures, Patient reported outcome measures

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Sustained Olecranon type fracture of Mayo 2a or 2b Seeking healthcare in at the Skåne University Hospital in Lund and Malmö, Sweden. Exclusion Criteria: Subjects unable to participate in follow up (for example subjects with active substance abuse, dementia, inability to communicate or understand the questionnaires or subjects living in other administrative healthcare regions). Subjects unable to give informed written consent. Subject where non operative treatment is indicated due to frailty or severe ongoing disease. Fracture not operated within 14 days from the date the fracture was sustained. Subjects with severe open fractures of Gustilo-Anderson class III Subject with pathological fractures from metastatic disease. Subject with simultaneous or previous severe injury to the same arm are excluded for patient reported outcome measures but included for all other outcomes. Subjects with previously severe injuries to the same arm will be excludes for PROM analyses but included for reoperation and complication analyses. Subjects operated by an orthopedic trauma surgeons that did not attended our education on the study and the interventions, unless surgery is supervised by an orthopedic surgeon that has attended the education the subject will not be excluded.

Sites / Locations

  • Dept. of OrthopaedicsRecruiting
  • Dept. of OrthopaedicsRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Cerclage

Tension Band Wiring

Arm Description

Intervention by cerclage fixation.

Intervention by tension band wiring

Outcomes

Primary Outcome Measures

Re-operation rate 1.5 months.
Total re-operation rate of the operated elbow regardless of cause.
Re-operation rate 3 months.
Total re-operation rate of the operated elbow regardless of cause.
Re-operation rate 12 months.
Total re-operation rate of the operated elbow regardless of cause.
Re-operation rate 36 months.
Total re-operation rate of the operated elbow regardless of cause.

Secondary Outcome Measures

Complication rate 1.5 months.
Total complication rate.
Complication rate 3 months.
Total complication rate.
Complication rate 12 months.
Total complication rate.
Complication rate 36 months.
Total complication rate.
Complication severity 1.5 months.
Complication severity classified with the Clavien-Dindo Classification.
Complication severity 3 months.
Complication severity classified with the Clavien-Dindo Classification.
Complication severity 12 months.
Complication severity classified with the Clavien-Dindo Classification.
Complication severity 36 months.
Complication severity classified with the Clavien-Dindo Classification.
Quick-DASH 1.5 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Quick-DASH 3 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Quick-DASH 12 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Quick-DASH 36 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
SMFA 12 months
SMFA-questionnaire assessed by subjects. See reference PMID: 27994082 and 14763711
Pain level 1.5 months.
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Pain level 3 months.
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Pain level 12 months,
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Pain level 36 months.
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Overall satisfaction 1.5 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Overall satisfaction 3 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Overall satisfaction 12 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Overall satisfaction 36 months.
Subjective overall satisfaction level. Measured with a visual analog scale.

Full Information

First Posted
November 16, 2022
Last Updated
January 19, 2023
Sponsor
Region Skane
Collaborators
Lund University
search

1. Study Identification

Unique Protocol Identification Number
NCT05657899
Brief Title
The With Or Without Olecranon K-wires Trial
Acronym
WOW-OK
Official Title
The With Or Without Olecranon K-wire (WOW OK) Trial of Tension Band Wire Fixation Versus Cerclage Fixation Without K-wires in Displaced Stable Olecranon Fractures
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2023 (Actual)
Primary Completion Date
September 1, 2029 (Anticipated)
Study Completion Date
September 1, 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Region Skane
Collaborators
Lund University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Fractures of the elbow tip (olecranon) that leave the elbow joint stable but where the fracture ends are separated (Mayo type 2a and 2b) can be treated with pins and a metal wire (tension band wiring, TBW) or metal wiring alone (cerclage fixation, CF ). Previous studies have reported high re-operation and complication rates following TBW. The current study's hypothesis, based on two retrospective studies, is that CF of these fractures yield lower re-operation rates compared with TBW. The investigators also hypothesize that the overall complication rate will be lower following CF. The aim is to investigate this hypothesis in a randomized controlled trial. Patients that are 18 years or older with Mayo type 2a and 2b olecranon fractures at Skåne University hospital will be invited to the study. Participation is voluntary. Patients who accept participation will be randomly assigned to surgery by either TBW or cerclage fixation. Two hundred participants will be followed by physiotherapists for 36 months post-surgery assessing re-operations, complications, patient reported outcome, and elbow function.
Detailed Description
The complete study protocol including a detailed description of the trial will be published in a journal before the start of the trial. Olecranon fractures account for approximately 20% of all proximal fractures of the forearm. Stable, undisplaced fractures (Mayo type 1a and 1b) are routinely treated non-operatively, while displaced and unstable fractures (Mayo type 3a and 3b) are typically operated with plate fixation. Stable, displaced fractures (Mayo type 2a and 2b) are often treated with tension band wiring (TBW) or plate fixation. TBW is associated with soft tissue irritation and high re-operation rates with hardware removal, ranging from 25% to 84% in the literature. Plate fixation was associated with fewer re-operations compared with TBW in a randomized controlled trial, but complications following plate fixation were more severe. A Cochrane review from 2014 did not find any significant support favouring either of the two methods. Non-operative treatment of Mayo type 2a and 2b fractures can yield acceptable results in elderly patients, but is not routinely used in younger individuals with higher functional demands. Two previous retrospective studies from 2002 and 2021 reported that Mayo 2a and 2b fractures can be operated with cerclage fixation alone yielding half the re-operation rates when compared to TBW. As of April 2022 there are two studies (one active (NCT03280602) and one completed (NCT01391936)) comparing TBW vs plate fixation, three studies (two active (NCT04670900 and NCT04401462) and one terminated (NCT01397643)) comparing non-operative vs operative treatment in elderly and one active study (NCT04189185) comparing TBW vs suture fixation registered on this site. The hypothesis of the current study is that the re-operation rate and the complication rate will be lower following CF compared with TBW while yielding equal results in other outcome measures. The aim is to to investigate this in a prospective randomized clinical trial. Methodology: All patients presenting at Skåne University Hospital in Malmö and Lund, Sweden, with olecranon fractures of Mayo type 2a and 2b will be invited to participate in the study if they do not meet any exclusion criteria. Potential subjects will be asked to sign a consent form after receiving written and oral information about the trial. Subjects will be randomized 1:1 to surgery with TBW or cerclage. 200 subjects will be recruited based on sample size calculations derived from the re-operation frequency in a previous study (PMID: 34236459) Baseline descriptive data will be collected at inclusion or in the peri-operative period. Operation time, intra-operative effective radiation dose and radiation time will be recorded. Subjects will be invited to follow-up to a physiotherapist at 2 weeks, 6 weeks, 3 months, 12 months and 36 months after the operation assessing re-operations, complications, post-operative antibiotics, range of elbow motion, grip strength, the Quick Disabilities of the Arm, Shoulder and Hand score (Quick-DASH, references PMID: 8773720 and 6709254), overall patient satisfaction, pain, return to work and secondary dislocation. The Short Musculoskeletal Function Assessment (SMFA, references PMID: 27994082 and 14763711) score will be assessed 12 months post-operatively. The physiotherapist will be masked to the treatment method. At 6 months one radiograph will be collected for assessment of non-union. The primary outcome measure will be re-operations. Secondary outcome measures will be patient reported outcome measures and complications. Tertiary outcome measures are post-operative range of motion and grip strength, secondary dislocation rate, time to return to work after surgery, operation time, effective intra-operative radiation dose and radiation time. The hypothesis of the current study is that cerclage fixation will yield less re-operations, less overall complications and less severe complications while other outcome measures will be equal.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Olecranon Fracture
Keywords
Tension Band Wiring, Cerclage, Surgery, Elbow injuries, Forearm injuries, Ulna fractures, Patient reported outcome measures

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
The assessor of all outcome measures except assessment of a postoperative radiograph will be masked. When the radiograph is viewed the operative method will be apparent, but this assessor is not the same as for the other outcome measures.
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cerclage
Arm Type
Active Comparator
Arm Description
Intervention by cerclage fixation.
Arm Title
Tension Band Wiring
Arm Type
Active Comparator
Arm Description
Intervention by tension band wiring
Intervention Type
Procedure
Intervention Name(s)
Cerclage fixation
Intervention Description
The intervention is by surgical open reduction and internal fixation of the fracture using two 1.0mm cerclage.
Intervention Type
Procedure
Intervention Name(s)
Tension band wiring
Intervention Description
The intervention is by surgical open reduction and internal fixation of the fracture using a 1.0mm cerclage and two 1.6 mm k-wires as described in AO-guidelines.
Primary Outcome Measure Information:
Title
Re-operation rate 1.5 months.
Description
Total re-operation rate of the operated elbow regardless of cause.
Time Frame
Recorded at 1.5 months after intervention.
Title
Re-operation rate 3 months.
Description
Total re-operation rate of the operated elbow regardless of cause.
Time Frame
Recorded at 3 months after intervention.
Title
Re-operation rate 12 months.
Description
Total re-operation rate of the operated elbow regardless of cause.
Time Frame
Recorded at 12 months after intervention.
Title
Re-operation rate 36 months.
Description
Total re-operation rate of the operated elbow regardless of cause.
Time Frame
Recorded at 36 months after intervention.
Secondary Outcome Measure Information:
Title
Complication rate 1.5 months.
Description
Total complication rate.
Time Frame
Recorded at 1.5 months after intervention.
Title
Complication rate 3 months.
Description
Total complication rate.
Time Frame
Recorded at 3 months after intervention.
Title
Complication rate 12 months.
Description
Total complication rate.
Time Frame
Recorded at 12 months after intervention.
Title
Complication rate 36 months.
Description
Total complication rate.
Time Frame
Recorded at 36 months after intervention.
Title
Complication severity 1.5 months.
Description
Complication severity classified with the Clavien-Dindo Classification.
Time Frame
Recorded at 1.5 months after intervention.
Title
Complication severity 3 months.
Description
Complication severity classified with the Clavien-Dindo Classification.
Time Frame
Recorded at 3 months after intervention.
Title
Complication severity 12 months.
Description
Complication severity classified with the Clavien-Dindo Classification.
Time Frame
Recorded at 12 months after intervention.
Title
Complication severity 36 months.
Description
Complication severity classified with the Clavien-Dindo Classification.
Time Frame
Recorded at 36 months after intervention.
Title
Quick-DASH 1.5 months.
Description
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time Frame
1.5 months after intervention.
Title
Quick-DASH 3 months.
Description
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time Frame
3 months after intervention.
Title
Quick-DASH 12 months.
Description
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time Frame
12 months after intervention.
Title
Quick-DASH 36 months.
Description
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time Frame
36 months after intervention.
Title
SMFA 12 months
Description
SMFA-questionnaire assessed by subjects. See reference PMID: 27994082 and 14763711
Time Frame
12 months after intervention.
Title
Pain level 1.5 months.
Description
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time Frame
Recorded at 1.5 months after intervention
Title
Pain level 3 months.
Description
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time Frame
Recorded at 3 months after intervention.
Title
Pain level 12 months,
Description
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time Frame
Recorded at 12 months after intervention.
Title
Pain level 36 months.
Description
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time Frame
Recorded at 36 months after intervention.
Title
Overall satisfaction 1.5 months.
Description
Subjective overall satisfaction level. Measured with a visual analog scale.
Time Frame
Recorded at 1.5 months after intervention.
Title
Overall satisfaction 3 months.
Description
Subjective overall satisfaction level. Measured with a visual analog scale.
Time Frame
Recorded at 3 months after intervention.
Title
Overall satisfaction 12 months.
Description
Subjective overall satisfaction level. Measured with a visual analog scale.
Time Frame
Recorded at 12 months after intervention.
Title
Overall satisfaction 36 months.
Description
Subjective overall satisfaction level. Measured with a visual analog scale.
Time Frame
Recorded at 36 months after intervention.
Other Pre-specified Outcome Measures:
Title
Grip strength 0.5 months.
Description
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time Frame
Recorded at 0.5 months after intervention.
Title
Grip strength 1.5 months.
Description
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time Frame
Recorded at 1.5 months after intervention.
Title
Grip strength 3 months.
Description
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time Frame
Recorded at 3 months after intervention.
Title
Grip strength 12 months.
Description
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time Frame
Recorded at 12 months after intervention.
Title
Grip strength 36 months.
Description
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time Frame
Recorded at 36 months after intervention.
Title
Range of motion 0.5 months.
Description
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time Frame
Recorded at 0.5 months after intervention.
Title
Range of motion 1.5 months.
Description
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time Frame
Recorded at 1.5 months after intervention.
Title
Range of motion 3 months.
Description
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time Frame
Recorded at 3 months after intervention.
Title
Range of motion 12 months.
Description
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time Frame
Recorded at 12 months after intervention.
Title
Range of motion 36 months.
Description
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time Frame
Recorded at 36 months after intervention.
Title
Time to return to work 1.5 months.
Description
Time to return to work in days will be evaluated for all working subjects.
Time Frame
Recorded at 1.5 months after intervention.
Title
Time to return to work 3 months.
Description
Time to return to work in days will be evaluated for all working subjects.
Time Frame
Recorded at 3 months after intervention.
Title
Time to return to work 12 months.
Description
Time to return to work in days will be evaluated for all working subjects.
Time Frame
Recorded at 12 months after intervention.
Title
Time to return to work 36 months.
Description
Time to return to work in days will be evaluated for all working subjects.
Time Frame
Recorded at 36 months after intervention.
Title
Secondary dislocation rate.
Description
Secondary dislocation rate will be assessed with a one lateral view radiograph of the operated elbow.
Time Frame
6 months after intervention.
Title
Intra-operative fluoroscopy radiation level.
Description
Intra-operative fluoroscopy radiation DAP will be recorded at the time of surgery from the fluoroscopy machine used.
Time Frame
Peri-operative.
Title
Intra-operative fluoroscopy time.
Description
Intra-operative fluoroscopy time will be recorded at the time of surgery from the fluoroscopy machine used.
Time Frame
Peri-operative.
Title
Antibiotic treatment 1.5.
Description
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time Frame
Recorded at 1.5 months after intervention.
Title
Antibiotic treatment 3.
Description
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time Frame
Recorded at 3 months after intervention.
Title
Antibiotic treatment 12.
Description
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time Frame
Recorded at 12 months after intervention.
Title
Antibiotic treatment 36.
Description
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time Frame
Recorded at 36 months after intervention.
Title
Surgical time.
Description
Time from incision to completed wound closure will be recorded during surgery.
Time Frame
Peri-operative.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Sustained Olecranon type fracture of Mayo 2a or 2b Seeking healthcare in at the Skåne University Hospital in Lund and Malmö, Sweden. Exclusion Criteria: Subjects unable to participate in follow up (for example subjects with active substance abuse, dementia, inability to communicate or understand the questionnaires or subjects living in other administrative healthcare regions). Subjects unable to give informed written consent. Subject where non operative treatment is indicated due to frailty or severe ongoing disease. Fracture not operated within 14 days from the date the fracture was sustained. Subjects with severe open fractures of Gustilo-Anderson class III Subject with pathological fractures from metastatic disease. Subject with simultaneous or previous severe injury to the same arm are excluded for patient reported outcome measures but included for all other outcomes. Subjects with previously severe injuries to the same arm will be excludes for PROM analyses but included for reoperation and complication analyses. Subjects operated by an orthopedic trauma surgeons that did not attended our education on the study and the interventions, unless surgery is supervised by an orthopedic surgeon that has attended the education the subject will not be excluded.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel Wenger, MD, PhD
Phone
+46 73-815 15 50
Email
daniel.wenger@med.lu.se
First Name & Middle Initial & Last Name or Official Title & Degree
Gustav Cornefjord, MD
Phone
+46 70-561 45 35
Email
gustav.cornefjord@skane.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Wenger, MD, PhD
Organizational Affiliation
Department of Orthopedics, Skåne University Hospital and Lund University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept. of Orthopaedics
City
Lund
State/Province
Skåne
ZIP/Postal Code
22242
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gustav Cornefjord, MD
Email
gustav.cornefjord@med.lu.se
First Name & Middle Initial & Last Name & Degree
Daniel Wenger, MD, PhD
Email
daniel.wenger@med.lu.se
Facility Name
Dept. of Orthopaedics
City
Malmö
State/Province
Skåne
ZIP/Postal Code
20502
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniel Wenger, MD, PhD
Email
daniel.wenger@med.lu.se
First Name & Middle Initial & Last Name & Degree
Gustav Cornefjord, MD
Email
gustav.cornefjord@med.lu.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34236459
Citation
Wenger D, Cornefjord G, Rogmark C. Cerclage fixation without K-wires is associated with fewer complications and reoperations compared with tension band wiring in stable displaced olecranon fractures in elderly patients. Arch Orthop Trauma Surg. 2022 Oct;142(10):2669-2676. doi: 10.1007/s00402-021-04027-3. Epub 2021 Jul 8.
Results Reference
background
PubMed Identifier
8773720
Citation
Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996 Jun;29(6):602-8. doi: 10.1002/(SICI)1097-0274(199606)29:63.0.CO;2-L. Erratum In: Am J Ind Med 1996 Sep;30(3):372.
Results Reference
background
PubMed Identifier
6709254
Citation
Gries MW. Safety professional's role as health educator expanding. Occup Health Saf. 1984 Feb:42-3. No abstract available.
Results Reference
background
PubMed Identifier
27994082
Citation
Williams N. The Short Musculoskeletal Function Assessment (SMFA) questionnaire. Occup Med (Lond). 2016 Dec;66(9):757. doi: 10.1093/occmed/kqw140. No abstract available.
Results Reference
background
PubMed Identifier
14763711
Citation
Ponzer S, Skoog A, Bergstrom G. The Short Musculoskeletal Function Assessment Questionnaire (SMFA): cross-cultural adaptation, validity, reliability and responsiveness of the Swedish SMFA (SMFA-Swe). Acta Orthop Scand. 2003 Dec;74(6):756-63. doi: 10.1080/00016470310018324.
Results Reference
background

Learn more about this trial

The With Or Without Olecranon K-wires Trial

We'll reach out to this number within 24 hrs